Innovations Transforming Health and Industry
Confmeets Journals presents its Biotechnology category, focusing on breakthrough research that merges biology with technology to revolutionize medicine, agriculture, and industrial applications. With a dedicated emphasis on Stem Cells and Tissue Engineering, this category offers a platform for scientists, clinicians, and innovators to share pioneering studies that reshape regenerative medicine and therapeutic solutions for the future.
Journal of Stem Cells and Tissue Engineering
Scope: This journal highlights research in stem cell biology, regenerative medicine, biomaterials, tissue repair, 3D bioprinting, and cellular therapies. It emphasizes translational studies that bridge laboratory discoveries with clinical applications, aiming to advance treatments for degenerative diseases, organ repair, and personalized medicine.
Market Insight: The global stem cell and tissue engineering market is projected to surpass $75 billion by 2030, driven by advancements in regenerative therapies, biopharmaceutical innovation, and growing investments in cell-based research.
Regional Focus:
